Cyclic peptides gain pharmaceutical industry momentum as Merck candidate earns FDA priority review
In this Eye on Patents column, we explore the pharmaceutical industry’s embrace of these circular molecules
Read the full articleYou might also wanna read
Compounded peptides placed on restrictive list by FDA, lawsuit filed
The FDA is evaluating the future of compounded peptides, which are popular short-chain amino acids that signal cells to perform specific bio
FDA Set To Back Peptide Drugs, Putting Hims & Hers (NYSE: HIMS) And Novo Nordisk (NYSE: NVO) In Focus
Peptides, short-chain amino acids formulated into pharmaceutical compounds, are drawing fresh regulatory attention from the Trump administra
Eli Lilly’s Michael Kopach says retatrutide leads in obesity treatment and CMC innovation
The pharma company’s latest peptide is so effective, it’s raising eyebrows among medical professionals.
Croatian researchers thrust into limelight as their 1990s’ peptide discovery goes mainstream in the US
Trump administration hopes to approve peptides popular with MAHA wellbeing advocates. How are the researchers at the centre of this coping w
How new weight-loss drugs may offer hope for curbing addiction
Drugmakers are racing to develop ever newer versions of the GLP-1 drugs, and regulators around the world are approving them at an equally ra
Ascletis Advances Obesity Pipeline With Two FDA IND Filings for Long-Acting Injectable Candidates
As reported on PharmaBiz, Ascletis Pharma has announced the submission of two Investigational New Drug (IND) applications to the US Food and
Comments
Sign in to join the conversation.
No comments yet. Be the first.